Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial

BACKGROUND: Although clozapine is the treatment of choice for treatment-refractory schizophrenia, 30–40% of patients have an insufficient response, and others are unable to tolerate it. Evidence for any augmentation strategies is scarce. We aimed to determine whether cognitive behavioural therapy (C...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet Psychiatry
Main Authors: Morrison, Anthony P, Pyle, Melissa, Gumley, Andrew, Schwannauer, Matthias, Turkington, Douglas, MacLennan, Graeme, Norrie, John, Hudson, Jemma, Bowe, Samantha E, French, Paul, Byrne, Rory, Syrett, Suzy, Dudley, Robert, McLeod, Hamish J, Griffiths, Helen, Barnes, Thomas R E, Davies, Linda, Kingdon, David
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6063993/
https://ncbi.nlm.nih.gov/pubmed/30001930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2215-0366(18)30184-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki